期刊文献+

膀胱癌组织VEGF-C表达与淋巴管生成和淋巴结转移之间关系的研究 被引量:5

Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in bladder transitional cell carcinoma
下载PDF
导出
摘要 目的:应用特异的淋巴管内皮标志物podoplanin检测膀胱移行细胞癌(BTCC)组织中淋巴管,用淋巴管密度(LVD)表示淋巴管生成情况,探讨BTCC内VEGF-C表达与淋巴管生成和淋巴结转移的关系。方法:收集45例BTCC和10例正常膀胱组织标本,应用免疫组化检测VEGF-C、podoplanin的表达,计算VEGF-C阳性表达率及淋巴管密度值,分析两者的关系。结果:BTCC组织内VEGF-C阳性表达率显著高于正常膀胱组织(71.1%vs.10.0%,P<0.01);BTCC高中分化和低分化之间VEGF-C阳性表达率无显著性差异(70.6%vs.72.7%,P>0.05),而淋巴结阳性组显著高于淋巴结阴性组(81.3%vs.65.5%,P<0.05)。BTCC组织内LVD显著高于正常膀胱组织(6.8±1.3vs.1.2±0.3,P<0.01);BTCC中,VEGF-C阳性组LVD显著高于VEGF-C阴性组(7.6±1.5vs.4.7±0.9,P<0.05),而淋巴结阳性组显著高于淋巴结阴性组(8.3±1.4vs.5.1±1.1,P<0.05)。结论:淋巴管生成可能是BTCC淋巴结转移的重要因素,VEGF-C参与BTCC淋巴管生成,从而促进淋巴结转移。 Objective:To explore the relationship between VEGF-C and lymphangiogenesis and lymphnode metastasis in bladder transitional cell carcinoma(BTCC) with the use of podoplanin, a specific lymphaticvessel endothelium marker to detect lymphatic vessel. Methods:The expression of VEGF-C and podoplanin were detected in 45 paraffin sections of BTCC and 10 cases of normal bladder tissue as control by imnmnohistochemist~'(SP). Assessments of podoplanin, lymphatic vessel density(LVD) and positive rates of VEGF-C were performed and their relationship was analysed. Results:The positive rate of VEGF-C in the normal bladder tissue group was significantly lower than that in the BTCC group( 10. 0% vs. 71. 1% , P 〈0. 01 ) , the positive rate of VEGF-C in the positive lymphnode group was significantly higher than that in the negative lymphnode metastasis group( 81.3% vs. 65.5% , P 〈0. 05 ) and there was no difference between the well differentiated group and the poor differentiated group(70.6% vs. 72. 7% , P 〉0. 05 ). LVD in the normal bladder tissue group( 1.2±0. 3 ) was distinctly lower than that in the BTCC group(6.8 ± 1.3 ) (P 〈 0. 01 ), LVD in the positive VEGF-C group was significantly higher than that in the negative VEGF-C group(7. 6 ± 1.5 vs. 4. 7 ±0. 9, P〈0. 05) and compared with the negative lymph node metastasis group(5. 1 ± 1. 1 ), LVD( 8.3 ± 1.4) in the positive lymph node metastasis group in creased significantly(P 〈 0. 05 ). Conclusion:Lymphangiogenesis is a significant factor for tumor lymphatic metastasis, VEGF-C may mediate lymphatic metastasis of BTCC by the way of inducing lymphangiogenesis.
出处 《临床肿瘤学杂志》 CAS 2008年第8期721-723,共3页 Chinese Clinical Oncology
关键词 膀胱移行细胞癌 PODOPLANIN 血管内皮生长因子C 淋巴管生成 Bladder trallsitional cell carcinoma( BTCC) Podoplanin Vascular endothelial growth factor C(VEGF-C) Lymphangiogenesis
  • 相关文献

参考文献5

  • 1Breiteneder-Geleff S,Soleiman A,Kowalski H,et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium [ J ]. Am J Pathol, 1999,154 ( 2 ) :385 - 394.
  • 2王艳,孙建国,叶明福,陈正堂.Podoplanin阳性淋巴管密度与非小细胞肺癌预后的关系[J].中华结核和呼吸杂志,2006,29(11):758-761. 被引量:8
  • 3Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis [J]. Nat Med,2001,7(2):192-198.
  • 4Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vaseular endo-thelial growth factor receptor (VEGFR)-3 in gastric cancer [J]. Eur J Cancer,2001,37 ( 7 ) :918 - 923.
  • 5Ristimaki A, Narko K, Eriholm B, et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C[J]. J Biol Chem,1998,273 (14) :8413 -8418.

二级参考文献7

  • 1Banerji S,Ni J,Wang SX,et al.LYVE-1,a new homologue of the CD44 glycoprotein,is a lymph-specific receptor for hyaluronan.J Cell Biol,1999,144:789-801.
  • 2Breiteneder-Geleff S,Soleiman A,Horvat R,et al.Podoplanin-a specific marker for lymphatic endothelium expressed in angiosarcoma.Verh Dtsch Ges Pathol,1999,83:270-275.
  • 3Kaipainen A,Korhonen J,Mustonen T,et al.Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.Proc Natl Acad Sci U S A,1995,92:3566-3570.
  • 4Mountain CF.Revisions in the international system for lung cancer.Chest:TNM classification of malignant tumors.5th ed.New York:Wiley-Liss,1997.1710-1717.
  • 5Travis WD,Colby TV,Corrin B,et al.Histological typing of lung and pleural tumors.World Health Organization International Histological Classification of Tumors.3rd ed.Berlin:Springer,1999.21-66.
  • 6Travis WD,Brambilla E,Muller-Hermelink HK,et al.Tumours of the lung,pleura,thymus and heart.Pathology and genetics:World Health Organization Classification of Tumours.Lyon:IARC Press,2004.105-106.
  • 7Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma.J Natl Cancer Inst,1992,84:1875-1887.

共引文献7

同被引文献35

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部